U.S. market Closed. Opens in 1 day 2 hours 16 minutes

VRNA | Verona Pharma plc Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-31
RevenueN/A458.00K40.00MN/A2.35K2.78K1.84MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue679.62K346.00KN/A627.85K512.11KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit-679.62K112.00K40.00M-627.85K-509.76K2.78K1.84MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Expenses67.15M66.23M97.68M66.01M53.41M32.48M40.16M8.49M13.29M5.90M4.64M4.18M2.87M2.93M2.60M2.17M2.61M1.31M12.04K
Selling, General & Admin49.87M26.58M33.91M29.77M8.99M7.99M8.10M2.89M2.51M1.80M1.91M1.47M1.12M1.09M1.05M827.39K894.40K1.05M18.93K
Research & Development17.28M49.28M79.41M44.51M43.89M24.48M32.05M5.58M10.76M4.10M2.73M2.71M1.46M1.78M1.53M1.29M1.50M266.45KN/A
Other Operating ExpensesN/A-9.63M-15.63M-8.27M527.09K16.50K23.00K1.07M1.17MN/AN/A0268.60K43.22K11.32K61.51K196.33KN/A-113.56K
Operating Income-67.83M-66.12M-73.31M-74.28M-53.87M-32.47M-40.21M-8.66M-13.29M-5.90M-4.64M-4.18M-2.87M-2.93M-2.60M-2.17M-2.61M-1.31M-12.04K
Other Expenses / Income12.62M7.30M-1.37M6.78M8.99M1.46M4.55M1.05M-28.00K29.98K2.63K32.61K6.21K12.35K11.32K203.55K192.36K123.43K56.78K
Before Tax Income-55.21M-68.45M-55.59M-65.00M-51.41M-30.62M-34.06M-7.37M-13.22M-5.86M-4.64M-4.15M-2.86M-2.91M-2.59M-1.97M-2.41M-1.19M44.74K
Income Tax Expenses-632.44K253.00K-18.00K146.00K-9.53M-5.37M-6.36M-1.18M-2.24M-1.56M-477.22K-77.68K-192.52K7.72K-24.25K41.00K192.36K123.43KN/A
Net Income-54.37M-68.70M-55.57M-65.15M-41.88M-25.25M-27.70M-6.19M-10.99M-4.29M-4.16M-4.07M-2.67M-2.92M-2.59M-2.01M-2.41M-1.19M44.74K
Interest Expenses2.06M521.00K340.00K35.00K221.59KN/A98.65K104.52KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding79.27M66.13M59.15M32.87M13.17M131.39M109.69M2.09B1.26B1.08B426.96M383.28M304.31M298.45M269.43M261.38M180.51M96.58M55.94M
Diluted Shares Outstanding79.27M66.13M59.15M32.87M13.17M131.39M109.69M2.09B1.26B1.08B426.96M383.28M304.31M298.45M269.43M261.38M180.51M96.58M68.26M
EBITDA-52.47M-67.29M-42.19M-47.81M-32.17M-25.50M-29.64M-6.96M-8.92M-3.74M-2.78M-2.56M-2.86M-2.88M-2.59M-1.94M-2.39M-1.19M-12.04K
EBITDA Margin0.00%-14,692.36%-105.47%0.00%-1,368,177.88%-916,205.53%-1,609.89%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-52.94M-67.93M-55.25M-64.97M-51.18M-30.62M-33.96M-7.26M-13.22M-5.86M-4.64M-4.15M-2.86M-2.91M-2.61M-1.97M-2.22M-1.07M44.74K
EBIT Margin0.00%-14,831.22%-138.12%0.00%-2,177,115.39%-1,100,342.28%-1,844.70%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙